Cancer Hospital Operator Launches New Oncology Facility In Bengaluru With Karnataka’s First MR-Linac

The Indian equity markets traded marginally higher on Tuesday, with the benchmark Nifty 50 index rising 0.04 per cent to 23,658.25 during the session. Healthcare and hospital stocks remained in focus amid expansion in advanced medical infrastructure and oncology care services across India. In this segment, HealthCare Global Enterprises Ltd witnessed buying interest after the company announced launch of a new comprehensive cancer hospital in North Bengaluru. On Tuesday, HCG share price gained 2.37 per cent to Rs 647.25.

HCG Launches New Cancer Hospital In Hebbal

HealthCare Global Enterprises informed exchanges that the company launched a new comprehensive cancer hospital in Byatarayanapura (Hebbal), North Bengaluru. The company stated that the facility has been launched to strengthen access to advanced oncology care in the region.

According to the filing, the new facility with up to 132 beds introduces Karnataka’s first Elekta Unity MR-Linac, described by the company as one of the world’s most advanced precision radiation therapy platforms. The technology combines MRI imaging with a linear accelerator to enable adaptive and highly precise cancer treatment.

The company stated that the hospital has been designed as a full-spectrum oncology centre bringing together diagnosis, treatment, recovery support and patient-centric care under one roof.

Advanced Oncology Infrastructure

HCG stated that the hospital is equipped with Accuray TomoTherapy with Radixact and an 80-slice Digital PET-CT scanner for diagnostic imaging and radiation oncology services.

The facility also includes five robotic-assisted modular operation theatres, 19 chemotherapy daycare beds, 14 premium treatment bays and a 15-bed ICU and HDU setup. Additional services include endoscopy, bronchoscopy, ultrasound, X-ray, mammography, histopathology and blood storage facilities.

The company further stated that the total built-up area of the facility is around 1,75,086 square feet and the centre has been developed as a comprehensive cancer management hub supported by multidisciplinary oncology care.

Management Commentary

Dr. B. S. Ajaikumar, Founder & Chairman of HealthCare Global Enterprises Ltd, stated that cancer care is becoming increasingly data-driven and technology-oriented with focus on improving long-term outcomes through personalised multidisciplinary treatment. He added that the Hebbal facility marks an important step in precision-led cancer treatment and strengthens the company’s commitment towards improving accessibility to advanced oncology care.

Dr. Manish Mattoo, Executive Director & CEO, HealthCare Global Enterprises Ltd, stated that the new Hebbal facility combines people-centric care, multidisciplinary expertise and advanced technology including MR-Linac to strengthen technology-led oncology services in Karnataka.

About HealthCare Global Enterprises

HealthCare Global Enterprises Ltd operates a dedicated cancer hospital network across India and Africa with focus on oncology diagnosis, treatment and multidisciplinary cancer care services. The company operates 25 comprehensive cancer hospitals across multiple cities.

HCG provides medical oncology, radiation oncology, surgical oncology and advanced diagnostic services supported by technology-driven treatment infrastructure and specialised healthcare professionals.

What are your views on HCG’s expansion in advanced oncology infrastructure with the launch of its Hebbal cancer hospital? Share your thoughts in the comments below.
Disclaimer: This article is for informational purposes only and not investment advice.